Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 9/20 | 0.67 |
| ▸ | CXCL8 | P10145 | 10/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29349773 | 1.00 | CCKBR (0.67) | CCKBRCXCL8 | |
| SCHEMBL23928719 | 1.00 | CCKBR (0.67) | CCKBRCXCL8 | |
| SCHEMBL29150398 | 0.97 | CCKBR (0.62) | CCKBRCXCL8 | |
| SCHEMBL30339999 | 0.95 | CXCL8 (0.60) | CCKBRCXCL8 | |
| SCHEMBL30435302 | 0.94 | CXCL8 (0.60) | CCKBRCXCL8 | |
| SCHEMBL29360635 | 0.90 | CCKBR (0.57) | CCKBRCXCL8 | |
| SCHEMBL11566228 | 0.88 | PTGS1 (0.56) | CCKBRCXCL8 | |
| SCHEMBL29369719 | 0.87 | CXCL8 (0.69) | CCKBRCXCL8 | |
| SCHEMBL30435375 | 0.86 | CXCL8 (0.65) | CCKBRCXCL8 | |
| SCHEMBL29408673 | 0.86 | CCKBR (0.70) | CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1015 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122050814-A | Noninvasive early warning method and device for autoimmune gastritis | 首都医科大学附属北京友谊医院 | 2026-05-15 | — | — | CN | claimed |
| WO-2026089437-A1 | LIVER TISSUE-LIKE ORGANOID AND METHOD OF MANUFACTURING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2026-04-30 | — | — | WO | claimed |
| US-20260117188-A1 | LIVER TISSUE-LIKE ORGANOID AND METHOD OF MANUFACTURING THE SAME | KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) | 2026-04-30 | — | — | US | claimed |
| US-20250242007-A1 | COMPOSITIONS AND METHODS FOR INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER | CANCER ADVANCES INC. (US) | 2025-07-31 | — | — | US | claimed |
| US-20250164492-A1 | MARKERS FOR THE EARLY DETECTION OF COLON CELL PROLIFERATIVE DISORDERS | FREENOME HOLDINGS, INC. | 2025-05-22 | — | — | US | claimed |
| US-20250114317-A1 | Use of L-cysteine for improving the structure and function of gastric mucosa | BIOHIT OYJ (FI) | 2025-04-10 | — | — | US | claimed |
| EP-4533095-A2 | MARKERS FOR THE EARLY DETECTION OF COLON CELL PROLIFERATIVE DISORDERS | Freenome Holdings, Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| CN-119790166-A | Markers for early detection of colonic cell proliferative disorders | 福瑞诺姆控股公司 | 2025-04-08 | — | — | CN | claimed |
| US-20250108102-A1 | NOVEL FRAGMENTED CRS PEPTIDE EXHIBITING IMMUNE ENHANCEMENT ACTIVITY, AND USE THEREOF | ZYMEDI CO., LTD. (KR) | 2025-04-03 | — | — | US | claimed |
| CN-119375496-B | Tumor marker multi-item quality control product | 美康生物科技股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| US-20220177598-A1 | TARGETED DELIVERY OF IFN GAMMA USING ANTIBODY FUSION PROTEINS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-09 | — | — | US | claimed |
| CN-114460310-A | Colored latex microsphere and preparation method and application thereof | 天津康博尔生物基因技术有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-114441779-A | Bimodal immunochromatography kit for gastrin 17 and detection method thereof | 上海交通大学 | 2022-05-06 | — | — | CN | claimed |
| US-20220133839-A1 | PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S) | TXP PHARMA GMBH (CH) | 2022-05-05 | — | — | US | claimed |
| CN-114350742-A | Gastric cancer detection marker combination and application thereof | 海南松林生物科技有限责任公司 | 2022-04-15 | — | — | CN | claimed |
| CN-114354304-A | Easily degradable protein preservation matrix liquid and application thereof | 安徽惠邦生物工程有限公司 | 2022-04-15 | — | — | CN | claimed |
| US-11299542-B2 | Monoclonal antibodies to progastrin and their uses | LES LABORATORIES SERVIER (FR) | 2022-04-12 | — | — | US | claimed |
| CN-109806388-B | Immunomodulatory vaccines | S-目标疗法有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-109806387-B | Immunomodulatory vaccines | S-目标疗法有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-114121263-A | Artificial intelligence auxiliary early gastric cancer and lung cancer screening system | 绵阳富临医院有限公司 | 2022-03-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117188-A1 | LIVER TISSUE-LIKE ORGANOID AND METHOD OF MANUFACTURING THE SAME | HGF, FGF1, HDGF | CCKBR 274/4885CXCL8 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.